Clinical trial
Platform Study of Immunotherapy Combinations in Colorectal Cancer Liver Metastases
NCT06300463 is registered in ClinicalTrials.gov with Weill Medical College of Cornell University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Platform Study of Immunotherapy Combinations in Colorectal Cancer Liver Metastases
- Lead sponsor
- Weill Medical College of Cornell University
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- March 26, 2024
- Completion date
- December 31, 2027
- Enrollment
- 24 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
colorectal cancer, colorectal cancer metastatic, liver metastases